{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:15:12Z","timestamp":1790957712907,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,22]]},"DOI":"10.7759\/cureus.37999","type":"journal-article","created":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T06:30:40Z","timestamp":1682231440000},"source":"Crossref","is-referenced-by-count":3,"title":["Myocarditis Following COVID-19 Vaccination: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Nour","family":"Shaheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelraouf","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elmasry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarya","family":"Swed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhannad","family":"Wael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document","volume":"13","author":"Ammirati E","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, et al.. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020, 13:e007405. 10.1161\/CIRCHEARTFAILURE.120.007405","journal-title":"Circ Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800028","article-title":"Myocarditis","volume":"360","author":"Cooper LT Jr","year":"2009","unstructured":"Cooper LT Jr. Myocarditis. N Engl J Med. 2009, 360:1526-38. 10.1056\/NEJMra0800028","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/01652176.2020.1727993","article-title":"Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments","volume":"40","author":"Malik YS","year":"2020","unstructured":"Malik YS, Sircar S, Bhat S, et al.. Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q. 2020, 40:68-76. 10.1080\/01652176.2020.1727993","journal-title":"Vet Q"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.714170","article-title":"Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis","volume":"12","author":"Sharif N","year":"2021","unstructured":"Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front Immunol. 2021, 12:714170. 10.3389\/fimmu.2021.714170","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2021.06.019","article-title":"Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases","volume":"78","author":"Mansour J","year":"2021","unstructured":"Mansour J, Short RG, Bhalla S, Woodard PK, Verma A, Robinson X, Raptis DA. Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases. Clin Imaging. 2021, 78:247-9. 10.1016\/j.clinimag.2021.06.019","journal-title":"Clin Imaging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden LR","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, et al.. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021, 384:403-16. 10.1056\/NEJMoa2035389","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack FP","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al.. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020, 383:2603-15. 10.1056\/NEJMoa2034577","journal-title":"N Engl J Med"},{"key":"ref8","unstructured":"Myocarditis and Pericarditis After mRNA COVID-19 Vaccination\r\n. (2022). Accessed. March 19, 2023: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/myocarditis.html."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021, 144:471-84. 10.1161\/CIRCULATIONAHA.121.056135","journal-title":"Circulation"},{"key":"ref10","unstructured":"The Moderna COVID-19 Vaccine\u2019s Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events. (2022). Accessed. March 19, 2023: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/moderna\/reactogenicity.html."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009, 151:264-9, W64. 10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"key":"ref12","unstructured":"The Times of Israel | News from Israel, the Middle East and the Jewish World. (2022). Accessed. March 19, 2023: https:\/\/www.timesofisrael.com\/."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.NAJ.0000444496.24228.2c","article-title":"The systematic review: an overview","volume":"114","author":"Aromataris E","year":"2014","unstructured":"Aromataris E, Pearson A. The systematic review: an overview. Am J Nurs. 2014, 114:53-8. 10.1097\/01.NAJ.0000444496.24228.2c","journal-title":"Am J Nurs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-053427","article-title":"COVID-19 vaccination-associated myocarditis in adolescents","volume":"148","author":"Jain SS","year":"2021","unstructured":"Jain SS, Steele JM, Fonseca B, et al.. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics. 2021, 148:e2021053427. 10.1542\/peds.2021-053427","journal-title":"Pediatrics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1435","article-title":"Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study","volume":"373","author":"Li X","year":"2021","unstructured":"Li X, Ostropolets A, Makadia R, et al.. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. Br Med J. 2021, 373:n1435. 10.1136\/bmj.n1435","journal-title":"Br Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda N","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, et al.. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021, 385:1078-90. 10.1056\/NEJMoa2110475","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02183-3","article-title":"Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report","volume":"21","author":"Hasnie AA","year":"2021","unstructured":"Hasnie AA, Hasnie UA, Patel N, Aziz MU, Xie M, Lloyd SG, Prabhu SD. Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord. 2021, 21:375. 10.1186\/s12872-021-02183-3","journal-title":"BMC Cardiovasc Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2021.05.033","article-title":"Myocarditis following COVID-19 vaccination","volume":"16","author":"Albert E","year":"2021","unstructured":"Albert E, Aurigemma G, Saucedo J, Gerson DS. Myocarditis following COVID-19 vaccination. Radiol Case Rep. 2021, 16:2142-5. 10.1016\/j.radcr.2021.05.033","journal-title":"Radiol Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2021.e01197","article-title":"Acute myocarditis following administration of BNT162b2 vaccine","volume":"25","author":"Habib MB","year":"2021","unstructured":"Habib MB, Hamamyh T, Elyas A, Altermanini M, Elhassan M. Acute myocarditis following administration of BNT162b2 vaccine. IDCases. 2021, 25:e01197. 10.1016\/j.idcr.2021.e01197","journal-title":"IDCases"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2828","article-title":"Patients with acute myocarditis following mRNA COVID-19 vaccination","volume":"6","author":"Kim HW","year":"2021","unstructured":"Kim HW, Jenista ER, Wendell DC, et al.. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021, 6:1196-201. 10.1001\/jamacardio.2021.2828","journal-title":"JAMA Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2109975","article-title":"Myocarditis after Covid-19 mRNA vaccination","volume":"385","author":"Verma AK","year":"2021","unstructured":"Verma AK, Lavine KJ, Lin CY. Myocarditis after Covid-19 mRNA vaccination. N Engl J Med. 2021, 385:1332-4. 10.1056\/NEJMc2109975","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2021.04.005","article-title":"Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19","volume":"74","author":"Bautista Garc\u00eda J","year":"2021","unstructured":"Bautista Garc\u00eda J, Pe\u00f1a Ortega P, Bonilla Fern\u00e1ndez JA, C\u00e1rdenes Le\u00f3n A, Ram\u00edrez Burgos L, Caballero Dorta E. Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Rev Esp Cardiol (Engl Ed). 2021, 74:812-4. 10.1016\/j.rec.2021.04.005","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16590","article-title":"Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination","volume":"13","author":"Khogali F","year":"2021","unstructured":"Khogali F, Abdelrahman R. Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus. 2021, 13:e16590. 10.7759\/cureus.16590","journal-title":"Cureus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003235","article-title":"Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine","volume":"40","author":"Snapiri O","year":"2021","unstructured":"Snapiri O, Rosenberg Danziger C, Shirman N, et al.. Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. Pediatr Infect Dis J. 2021, 40:e360-3. 10.1097\/INF.0000000000003235","journal-title":"Pediatr Infect Dis J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.055913","article-title":"Myocarditis after BNT162b2 and mRNA-1273 vaccination","volume":"144","author":"Larson KF","year":"2021","unstructured":"Larson KF, Ammirati E, Adler ED, et al.. Myocarditis after BNT162b2 and mRNA-1273 vaccination. Circulation. 2021, 144:506-8. 10.1161\/CIRCULATIONAHA.121.055913","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2021.08.018","article-title":"Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients","volume":"340","author":"Abbate A","year":"2021","unstructured":"Abbate A, Gavin J, Madanchi N, et al.. Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int J Cardiol. 2021, 340:119-21. 10.1016\/j.ijcard.2021.08.018","journal-title":"Int J Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2021.07.044","article-title":"Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18\u00a0years of age","volume":"238","author":"Das BB","year":"2021","unstructured":"Das BB, Kohli U, Ramachandran P, et al.. Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18\u00a0years of age. J Pediatr. 2021, 238:26-32.e1. 10.1016\/j.jpeds.2021.07.044","journal-title":"J Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2021.06.083","article-title":"Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents","volume":"238","author":"Schauer J","year":"2021","unstructured":"Schauer J, Buddhe S, Colyer J, Sagiv E, Law Y, Mallenahalli Chikkabyrappa S, Portman MA. Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. J Pediatr. 2021, 238:317-20. 10.1016\/j.jpeds.2021.06.083","journal-title":"J Pediatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.33963\/KP.a2021.0075","article-title":"Every rose has its thorns - acute myocarditis following COVID-19 vaccination","volume":"79","author":"Sokolska JM","year":"2021","unstructured":"Sokolska JM, Kurcz J, Kosmala W. Every rose has its thorns - acute myocarditis following COVID-19 vaccination. Kardiol Pol. 2021, 79:1153-4. 10.33963\/KP.a2021.0075","journal-title":"Kardiol Pol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056038","article-title":"In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine","volume":"144","author":"Muthukumar A","year":"2021","unstructured":"Muthukumar A, Narasimhan M, Li QZ, et al.. In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine. Circulation. 2021, 144:487-98. 10.1161\/CIRCULATIONAHA.121.056038","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951121002547","article-title":"Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine","volume":"32","author":"Park J","year":"2022","unstructured":"Park J, Brekke DR, Bratincsak A. Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiol Young. 2022, 32:146-9. 10.1017\/S1047951121002547","journal-title":"Cardiol Young"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211029230","article-title":"Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database","volume":"12","author":"Deb A","year":"2021","unstructured":"Deb A, Abdelmalek J, Iwuji K, Nugent K. Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. J Prim Care Community Health. 2021, 12:21501327211029230. 10.1177\/21501327211029230","journal-title":"J Prim Care Community Health"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.09.004","article-title":"Myocarditis following COVID-19 vaccination - a case series","volume":"39","author":"Levin D","year":"2021","unstructured":"Levin D, Shimon G, Fadlon-Derai M, et al.. Myocarditis following COVID-19 vaccination - a case series. Vaccine. 2021, 39:6195-200. 10.1016\/j.vaccine.2021.09.004","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2021.06.035","article-title":"Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent","volume":"238","author":"Minocha PK","year":"2021","unstructured":"Minocha PK, Better D, Singh RK, Hoque T. Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. J Pediatr. 2021, 238:321-3. 10.1016\/j.jpeds.2021.06.035","journal-title":"J Pediatr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102277","article-title":"Corrigendum to \"COVID-19 vaccine-induced myocarditis case report with literature review\" [Diabetes & Metabolic Syndrome: Clinical Research & Reviews Volume 15, Issue 5, September-October 2021, 102205]","volume":"15","author":"Nassar M","year":"2021","unstructured":"Nassar M, Nso N, Gonzalez C, et al.. Corrigendum to \"COVID-19 vaccine-induced myocarditis case report with literature review\" [Diabetes & Metabolic Syndrome: Clinical Research & Reviews Volume 15, Issue 5, September-October 2021, 102205]. Diabetes Metab Syndr. 2021, 15:102277. 10.1016\/j.dsx.2021.102277","journal-title":"Diabetes Metab Syndr"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.06.051","article-title":"Myocarditis after BNT162b2 vaccination in a healthy male","volume":"50","author":"Watkins K","year":"2021","unstructured":"Watkins K, Griffin G, Septaric K, Simon EL. Myocarditis after BNT162b2 vaccination in a healthy male. Am J Emerg Med. 2021, 50:815.e1-2. 10.1016\/j.ajem.2021.06.051","journal-title":"Am J Emerg Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-052478","article-title":"Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination","volume":"148","author":"Marshall M","year":"2021","unstructured":"Marshall M, Ferguson ID, Lewis P, et al.. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics. 2021, 148:e2021052478. 10.1542\/peds.2021-052478","journal-title":"Pediatrics"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.087","article-title":"Myocarditis following COVID-19 mRNA vaccination","volume":"39","author":"Abu Mouch S","year":"2021","unstructured":"Abu Mouch S, Roguin A, Hellou E, et al.. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021, 39:3790-3. 10.1016\/j.vaccine.2021.05.087","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021211430","article-title":"Myocarditis associated with mRNA COVID-19 vaccination","volume":"301","author":"Starekova J","year":"2021","unstructured":"Starekova J, Bluemke DA, Bradham WS, Grist TM, Schiebler ML, Reeder SB. Myocarditis associated with mRNA COVID-19 vaccination. Radiology. 2021, 301:E409-11. 10.1148\/radiol.2021211430","journal-title":"Radiology"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.3471","article-title":"Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children","volume":"6","author":"Dionne A","year":"2021","unstructured":"Dionne A, Sperotto F, Chamberlain S, et al.. Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. 2021, 6:1446-50. 10.1001\/jamacardio.2021.3471","journal-title":"JAMA Cardiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021211766","article-title":"Myocarditis following COVID-19 vaccination","volume":"301","author":"Isaak A","year":"2021","unstructured":"Isaak A, Feisst A, Luetkens JA. Myocarditis following COVID-19 vaccination. Radiology. 2021, 301:E378-9. 10.1148\/radiol.2021211766","journal-title":"Radiology"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2833","article-title":"Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US Military","volume":"6","author":"Montgomery J","year":"2021","unstructured":"Montgomery J, Ryan M, Engler R, et al.. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US Military. JAMA Cardiol. 2021, 6:1202-6. 10.1001\/jamacardio.2021.2833","journal-title":"JAMA Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.055891","article-title":"Myocarditis temporally associated with COVID-19 vaccination","volume":"144","author":"Rosner CM","year":"2021","unstructured":"Rosner CM, Genovese L, Tehrani BN, et al.. Myocarditis temporally associated with COVID-19 vaccination. Circulation. 2021, 144:502-5. 10.1161\/CIRCULATIONAHA.121.055891","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.5152\/AnatolJCardiol.2021.99","article-title":"Acute myocarditis after the second dose of SARS-CoV-2 vaccine: serendipity or atypical causal relationship?","volume":"25","author":"Cereda A","year":"2021","unstructured":"Cereda A, Conca C, Barbieri L, et al.. Acute myocarditis after the second dose of SARS-CoV-2 vaccine: serendipity or atypical causal relationship?. Anatol J Cardiol. 2021, 25:522-3. 10.5152\/AnatolJCardiol.2021.99","journal-title":"Anatol J Cardiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14322","article-title":"Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: a case report","volume":"28","author":"McLean K","year":"2021","unstructured":"McLean K, Johnson TJ. Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: a case report. Acad Emerg Med. 2021, 28:918-21. 10.1111\/acem.14322","journal-title":"Acad Emerg Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.7774\/cevr.2021.10.2.196","article-title":"Acute myocarditis associated with anti-COVID-19 vaccination","volume":"10","author":"Nevet A","year":"2021","unstructured":"Nevet A. Acute myocarditis associated with anti-COVID-19 vaccination. Clin Exp Vaccine Res. 2021, 10:196-7. 10.7774\/cevr.2021.10.2.196","journal-title":"Clin Exp Vaccine Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2021.100042","article-title":"Myocarditis following mRNA vaccination against SARS-CoV-2, a case series","volume":"8","author":"King WW","year":"2021","unstructured":"King WW, Petersen MR, Matar RM, Budweg JB, Cuervo Pardo L, Petersen JW. Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. Am Heart J Plus. 2021, 8:100042. 10.1016\/j.ahjo.2021.100042","journal-title":"Am Heart J Plus"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2021.06.003","article-title":"A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2","volume":"14","author":"Dickey JB","year":"2021","unstructured":"Dickey JB, Albert E, Badr M, et al.. A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging. 2021, 14:1862-3. 10.1016\/j.jcmg.2021.06.003","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2021.07.082","article-title":"Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection","volume":"16","author":"Patrignani A","year":"2021","unstructured":"Patrignani A, Schicchi N, Calcagnoli F, Falchetti E, Ciampani N, Argalia G, Mariani A. Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Rep. 2021, 16:3321-5. 10.1016\/j.radcr.2021.07.082","journal-title":"Radiol Case Rep"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2021.08.012","article-title":"Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: a case report and literature review","volume":"38","author":"Sulemankhil I","year":"2022","unstructured":"Sulemankhil I, Abdelrahman M, Negi SI. Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: a case report and literature review. Cardiovasc Revasc Med. 2022, 38:117-23. 10.1016\/j.carrev.2021.08.012","journal-title":"Cardiovasc Revasc Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10061018","article-title":"COVID-19 pandemic-revealed consistencies and inconsistencies in healthcare: a medical and organizational view","volume":"10","author":"Araja D","year":"2022","unstructured":"Araja D, Berkis U, Murovska M. COVID-19 pandemic-revealed consistencies and inconsistencies in healthcare: a medical and organizational view. Healthcare (Basel). 2022, 10:1018. 10.3390\/healthcare10061018","journal-title":"Healthcare (Basel)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.12498","article-title":"Myocarditis and pericarditis after vaccination for COVID-19","volume":"2","author":"Hudson B","year":"2021","unstructured":"Hudson B, Mantooth R, DeLaney M. Myocarditis and pericarditis after vaccination for COVID-19. J Am Coll Emerg Physicians Open. 2021, 2:e12498. 10.1002\/emp2.12498","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piab060","article-title":"Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine","volume":"10","author":"Tano E","year":"2021","unstructured":"Tano E, San Martin S, Girgis S, Martinez-Fernandez Y, Sanchez Vegas C. Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. J Pediatric Infect Dis Soc. 2021, 10:962-6. 10.1093\/jpids\/piab060","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref54","unstructured":"Possible Side Effects After Getting a COVID-19 Vaccine. (2022). Accessed. March 20, 2023: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/expect\/after.html."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.108","article-title":"Viral myocarditis--diagnosis, treatment options, and current controversies","volume":"12","author":"Pollack A","year":"2015","unstructured":"Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis--diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015, 12:670-80. 10.1038\/nrcardio.2015.108","journal-title":"Nat Rev Cardiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000745","article-title":"Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association","volume":"141","author":"Kociol RD","year":"2020","unstructured":"Kociol RD, Cooper LT, Fang JC, et al.. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020, 141:e69-92. 10.1161\/CIR.0000000000000745","journal-title":"Circulation"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.23937\/2378-2951\/1410232","article-title":"COVID-19 mRNA vaccine induced troponinemia - is the vaccine a cardiac stressor?","volume":"8","author":"Acharya S","year":"2021","unstructured":"Acharya S, Brand M, Lee J, Macqueen D, Arbach A, Bhattarai S. COVID-19 mRNA vaccine induced troponinemia - is the vaccine a cardiac stressor?. Int J Clin Cardiol. 2021, 8:232. 10.23937\/2378-2951\/1410232","journal-title":"Int J Clin Cardiol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio AL","year":"2013","unstructured":"Caforio AL, Pankuweit S, Arbustini E, et al.. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013, 34:2636-48, 2648a-2648d. 10.1093\/eurheartj\/eht210","journal-title":"Eur Heart J"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper","volume":"53","author":"Friedrich MG","year":"2009","unstructured":"Friedrich MG, Sechtem U, Schulz-Menger J, et al.. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009, 53:1475-87. 10.1016\/j.jacc.2009.02.007","journal-title":"J Am Coll Cardiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60648-X","article-title":"Myocarditis","volume":"379","author":"Sagar S","year":"2012","unstructured":"Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet. 2012, 379:738-47. 10.1016\/S0140-6736(11)60648-X","journal-title":"Lancet"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm076","article-title":"A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis","volume":"28","author":"Caforio AL","year":"2007","unstructured":"Caforio AL, Calabrese F, Angelini A, et al.. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J. 2007, 28:1326-33. 10.1093\/eurheartj\/ehm076","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/144455-myocarditis-following-covid-19-vaccination-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:36Z","timestamp":1707508536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/144455-myocarditis-following-covid-19-vaccination-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,22]]},"references-count":61,"URL":"https:\/\/doi.org\/10.7759\/cureus.37999","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,22]]}}}